Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
You need to sign in or sign up before continuing.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth


Innospec Inc. IOSP reported second-quarter 2026 adjusted earnings of $1.27 per share, up 0.8% year over year. The figure beat the Zacks Consensus Estimate of $1.05 by 21%.

Net income (as reported) attributable to Innospec rose to $30.8 million or $1.25 per share from $23.5 million or 94 cents a year earlier. 

Revenues rose 11.8% year over year to $491.4 million and surpassed the consensus estimate of $462.4 million by 6.4%. Growth was supported by all three businesses.

Total operating income increased 15.7% year over year to $39.7 million. Adjusted EBITDA rose 2% to $50.1 million. Gross profit increased to $138.3 million from $123.2 million a year ago, reflecting the higher sales base and contributions across the operating businesses.

Innospec Inc. Price, Consensus and EPS Surprise

Innospec Inc. Price, Consensus and EPS Surprise

Innospec Inc. price-consensus-eps-surprise-chart | Innospec Inc. Quote

Innospec's Segment Performance

Performance Chemicals revenues increased 9.5% year over year to $190.3 million. A 2% volume decline was more than offset by an 8% positive price/mix contribution and a 3% favorable currency impact.

The segment's gross margin edged down 0.2 percentage points to 17.3%. Operating income rose 14.7% to $16.4 million as operating leverage improved. Management said repairs, process improvements and upgrades at its North Carolina plants continued during the quarter.

Fuel Specialties revenues climbed 12.5% year over year to $185.7 million. Volumes increased 7%, price/mix contributed 3% and currency added 2%, providing a balanced mix of growth drivers.

Gross margin declined 1.5 percentage points to 36.6%, but operating income increased 2.5% to $36.3 million. Management said margins remained within its target range despite the year-over-year contraction.

Oilfield Services revenues rose 14.5% year over year to $115.4 million. The business benefited from Innospec's recent drag-reducing agent (DRA) plant expansion and growing opportunities to supply the technology to customers.

Operating income increased 40.3% to $8.7 million. Management also remained focused on growth and margin improvement in its United States and Middle East completions and production operations.

IOSP’s Financials

Cash provided by operating activities was $7.2 million in the quarter compared with $10.5 million a year ago. Capital expenditures totaled $16.5 million. Management expects operating cash flow to increase in the second half as working capital efficiency improves.

Innospec ended June with $250.2 million in cash and cash equivalents and no debt. The debt-free position leaves the company with flexibility to fund organic investment and potential acquisitions.

During the quarter, IOSP paid a semi-annual dividend of 92 cents per share and repurchased $6.4 million of common stock. Management also highlighted dividend growth and buybacks among its capital-allocation options alongside investment in the business.

Innospec Targets Further Second-Half Improvement

Management expects Performance Chemicals to benefit from ongoing plant repairs, process improvements, upgrades and additional topline and margin opportunities. These actions remain central to the company's plan for better second-half performance.

For Oilfield Services, Innospec expects its DRA expansion and opportunities in completions and production to support further sequential gains. Fuel Specialties, meanwhile, is expected to continue advancing opportunities across its established and newer end markets. The company continues to pursue opportunities across traditional fuel, renewable fuel and non-fuel applications. 

The company remains focused on technology development, topline growth and margin improvement across the portfolio. Management's outlook calls for further operating progress while preserving balance-sheet flexibility for investment and shareholder returns.

IOSP’s Stock Price Performance

Shares of Innospec have gained 12.4% in the past year compared with the Zacks Chemicals Diversified industry’s 6.1% rise.

Zacks Investment Research
Image Source: Zacks Investment Research

IOSP’s Zacks Rank & Key Picks

IOSP currently carries a Zacks Rank #2 (Buy).

Other top-ranked stocks in the Basic Materials space are Almonty Industries Inc. ALM, Neo Performance Materials Inc. NOPMF and Skeena Resources Limited SKE

Almonty is expected to report second-quarter results on Aug. 13. The Zacks Consensus Estimate for ALM’s second-quarter earnings is pegged at 10 cents per share. It carries a Zacks Rank #2 at present. 

NOPMF is slated to report second-quarter results on Aug. 11. The Zacks Consensus Estimate for earnings is pegged at 50 cents per share. NOPMF has a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here

Skeena Resources is expected to report second-quarter results on Aug. 13. The Zacks Consensus Estimate for SKE’s second-quarter loss is pegged at 11 cents per share. It currently carries a Zacks Rank #2. 

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Innospec Inc. (IOSP): Free Stock Analysis Report
 
Skeena Resources Limited (SKE): Free Stock Analysis Report
 
Almonty Industries Inc. (ALM): Free Stock Analysis Report
 
Neo Performance Materials Inc. (NOPMF): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Teilen
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Rechtlicher Hinweis

Kommentare